Bausch Health Companies Inc. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
Bausch Health Companies Inc. (BHC) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $8.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-30
- Bausch Health Companies Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-06-30 was $8.00M, a 166.67% increase year-over-year.
- Bausch Health Companies Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-03-31 was $34.00M, a 112.50% increase year-over-year.
- Bausch Health Companies Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-09-30 was $5.00M, a 0.00% change year-over-year.
- Bausch Health Companies Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $24.00M, a 7.69% decline from fiscal 2024.
- Bausch Health Companies Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $26.00M, a 8.33% increase from fiscal 2023.
- Bausch Health Companies Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $24.00M, a 22.58% decline from fiscal 2022.
- Bausch Health Companies Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $31.00M, a 40.38% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.00M 10-Q · filed 2026-07-30 | $42.00M 10-Q · filed 2026-07-30 | $42.00M derived: sum of 3 quarters · filed 2026-07-30 | $47.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $34.00M 10-Q · filed 2026-04-30 | $34.00M derived: sum of 2 quarters · filed 2026-04-30 | $39.00M derived: sum of 3 quarters · filed 2026-04-30 | $42.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $5.00M derived: sum of 2 quarters · filed 2026-02-19 | $8.00M derived: sum of 3 quarters · filed 2026-07-30 | $24.00M 10-K · filed 2026-02-19 |
| 2025-09-30 | $5.00M 10-Q · filed 2025-10-30 | $8.00M derived: sum of 2 quarters · filed 2026-07-30 | $24.00M 10-Q · filed 2025-10-30 | $27.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $3.00M 10-Q · filed 2026-07-30 | $19.00M 10-Q · filed 2026-07-30 | $22.00M derived: sum of 3 quarters · filed 2026-07-30 | $27.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $16.00M 10-Q · filed 2026-04-30 | $19.00M derived: sum of 2 quarters · filed 2026-04-30 | $24.00M derived: sum of 3 quarters · filed 2026-04-30 | $28.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $8.00M derived: sum of 2 quarters · filed 2026-02-19 | $12.00M derived: sum of 3 quarters · filed 2026-02-19 | $26.00M 10-K · filed 2026-02-19 |
| 2024-09-30 | $5.00M 10-Q · filed 2025-10-30 | $9.00M derived: sum of 2 quarters · filed 2025-10-30 | $23.00M 10-Q · filed 2025-10-30 | $24.00M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $4.00M 10-Q · filed 2025-07-31 | $18.00M 10-Q · filed 2025-07-31 | $19.00M derived: sum of 3 quarters · filed 2026-02-19 | $27.00M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $14.00M 10-Q · filed 2025-05-01 | $15.00M derived: sum of 2 quarters · filed 2026-02-19 | $23.00M derived: sum of 3 quarters · filed 2026-02-19 | $26.00M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $9.00M derived: sum of 2 quarters · filed 2026-02-19 | $12.00M derived: sum of 3 quarters · filed 2026-02-19 | $24.00M 10-K · filed 2026-02-19 |
| 2023-09-30 | $8.00M 10-Q · filed 2024-10-31 | $11.00M derived: sum of 2 quarters · filed 2024-10-31 | $23.00M 10-Q · filed 2024-10-31 | $24.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $3.00M 10-Q · filed 2024-08-01 | $15.00M 10-Q · filed 2024-08-01 | $16.00M derived: sum of 3 quarters · filed 2025-02-20 | $17.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $12.00M 10-Q · filed 2024-05-02 | $13.00M derived: sum of 2 quarters · filed 2025-02-20 | $14.00M derived: sum of 3 quarters · filed 2025-02-20 | $18.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $2.00M derived: sum of 2 quarters · filed 2025-02-20 | $6.00M derived: sum of 3 quarters · filed 2025-02-20 | $31.00M 10-K · filed 2025-02-20 |
| 2022-09-30 | $1.00M 10-Q · filed 2023-11-02 | $5.00M derived: sum of 2 quarters · filed 2023-11-02 | $30.00M 10-Q · filed 2023-11-02 | $34.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $4.00M 10-Q · filed 2023-08-03 | $29.00M 10-Q · filed 2023-08-03 | $33.00M derived: sum of 3 quarters · filed 2024-02-22 | $36.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $25.00M 10-Q · filed 2023-05-04 | $29.00M derived: sum of 2 quarters · filed 2024-02-22 | $32.00M derived: sum of 3 quarters · filed 2024-02-22 | $36.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $7.00M derived: sum of 2 quarters · filed 2024-02-22 | $11.00M derived: sum of 3 quarters · filed 2024-02-22 | $52.00M 10-K · filed 2024-02-22 |
| 2021-09-30 | $3.00M 10-Q · filed 2022-11-03 | $7.00M derived: sum of 2 quarters · filed 2022-11-03 | $48.00M 10-Q · filed 2022-11-03 | $48.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $4.00M 10-Q · filed 2022-08-09 | $45.00M 10-Q · filed 2022-08-09 | $45.00M derived: sum of 3 quarters · filed 2023-02-23 | $46.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $41.00M 10-Q · filed 2022-05-10 | $41.00M derived: sum of 2 quarters · filed 2023-02-23 | $42.00M derived: sum of 3 quarters · filed 2023-02-23 | $47.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.00M derived: sum of 2 quarters · filed 2023-02-23 | $6.00M derived: sum of 3 quarters · filed 2023-02-23 | $30.00M 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.00M 10-Q · filed 2021-11-02 | $6.00M derived: sum of 2 quarters · filed 2021-11-02 | $30.00M 10-Q · filed 2021-11-02 | $30.00M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-06-30 | $5.00M 10-Q · filed 2021-08-03 | $29.00M 10-Q · filed 2021-08-03 | $29.00M derived: sum of 3 quarters · filed 2022-05-11 | $30.00M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-03-31 | $24.00M 10-Q · filed 2021-05-04 | $24.00M derived: sum of 2 quarters · filed 2022-05-11 | $25.00M derived: sum of 3 quarters · filed 2022-05-11 | $30.00M derived: sum of 4 quarters · filed 2022-05-11 |
| 2019-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $1.00M derived: sum of 2 quarters · filed 2022-05-11 | $6.00M derived: sum of 3 quarters · filed 2022-05-11 | $40.00M 8-K · filed 2022-05-11 |
| 2019-09-30 | $1.00M 10-Q · filed 2020-11-03 | $6.00M derived: sum of 2 quarters · filed 2020-11-03 | $40.00M 10-Q · filed 2020-11-03 | $40.00M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-06-30 | $5.00M 10-Q · filed 2020-08-06 | $39.00M 10-Q · filed 2020-08-06 | $39.00M derived: sum of 3 quarters · filed 2021-05-04 | $40.00M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-03-31 | $34.00M 10-Q · filed 2020-05-07 | $34.00M derived: sum of 2 quarters · filed 2021-05-04 | $35.00M derived: sum of 3 quarters · filed 2021-05-04 | $38.00M derived: sum of 4 quarters · filed 2021-05-04 |
| 2018-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $1.00M derived: sum of 2 quarters · filed 2021-05-04 | $4.00M derived: sum of 3 quarters · filed 2021-05-04 | $10.00M 8-K · filed 2021-05-04 |
| 2018-09-30 | $1.00M 10-Q · filed 2019-11-04 | $4.00M derived: sum of 2 quarters · filed 2019-11-04 | $10.00M 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $3.00M 10-Q · filed 2019-08-06 | $9.00M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $6.00M 10-Q · filed 2019-05-06 | |||
| 2017-12-31 | $4.00M 10-K · filed 2020-02-19 | |||
| 2016-12-31 | $11.00M 10-K · filed 2019-02-20 | |||
| 2015-12-31 | $88.00M 8-K · filed 2018-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |